The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system
- 1 July 1992
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 64 (3), 249-256
- https://doi.org/10.1016/0304-3835(92)90050-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- 1-(Aminoalkyl)-2-phenylindoles as novel pure estrogen antagonistsJournal of Medicinal Chemistry, 1990
- Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitroBritish Journal of Cancer, 1989
- Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesisJournal of Neural Transmission, 1986
- Selection and Characterization of a Breast Cancer Cell Line Resistant to the Antiestrogen LY 117018Endocrinology, 1985
- Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen Receptor Positive Breast CancerScience, 1982
- Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistanceCell, 1982
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978